World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

RELATIONSHIP OF LIVER FUNCTION TEST WITH INTERDIALYTIC WEIGHT GAIN AND ITS COMPLICATIONS IN HEPATITIS C POSITIVE ESRD PATIENTS

Sania Siddiqa, Nimra Naeem, Shahzaib Ali, Dr. Aurangzaib Afzal and Azhar Hussain*

ABSTRACT

Background: Patients on hemodialysis are at increased risk of hepatitis C and are associated with increased mortality rate. The risk rate is 10 fold greater in hemodialytic patients than in general population because of the risk of nosocomial transmission. The prevalence of HCV among patients varies and is greater in developing countries. Objective: The aim of our study was to find any association between liver function tests (LFTs) and interdialytic weight gain(IDWG) in ESRD patients in hepatitis C infected patients with ESRD. Methods: We conducted this prospective cross sectional study in Department of nephrology and Dialysis centre, Lahore General Hospital, Lahore from December 2019 to February 2020.Patients of ESRD who attended the clinic hemodialysis were asked for their participation in this study. Consecutive patient schedule for dialysis were potentially asked to complete questionnaire. Quantitative determination of the liver function tests (LFTs), calcium, phosphate, bilirubin, albumin and complete blood count (CBC) were done. Pre-dialytic and post-dialytic weights were noted and interdialytic weight gain was calculated. Results: Out of total 56 patients of ESRD with HCV+, 21 were males and 35 were females. Mean for the ALT, AST, ALP, SGPT, SGOT and interdialytic weight gain were calculated. Paired sample T test results for both SGOT and SGPT with IDWG were statistically significant (p<0.01). Conclusion: lLFTs did correlate with interdialytic weight gain in hepatitis C infected patients with ESRD.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR